Tag: Imdevimab

Monoclonal Antibody Therapy Cuts Death Risk In COVID-19 Patients By 20%
Monoclonal Antibody Therapy Cuts Death Risk In COVID-19 Patients By 20%

Treatment with the therapy, which is a combination of two monoclonal antibodies -- Casirivimab and Imdevimab -- was touted as a game changer with its better hold on the deadly Covid pandemic by Indian hospitals.

COVID19: Roche Gets 'Emergency Use' Nod For Antibody Cocktail Jab In India
COVID19: Roche Gets 'Emergency Use' Nod For Antibody Cocktail Jab In India

Mumbai: The Central Drugs Standards Control Organisation (CDSCO) on Wednesday gave Roche India emergency use authorisation (EUA) for its antibody cocktail jab of Casirivimab and Imdevimab. The Casirivimab-Imdevimab injection is…